Assessing Optimal XRB Initiation Points in Jail
Start Date
6/2/2025
Completion Date
3/1/2027
Summary
This application describes a 3-year, randomized controlled trial. Eligible, consenting adults (N=200) with existing sublingual buprenorphine (SLB) prescriptions who enter Middlesex County House of Corrections (MCHOC) as pre-trial detainees will be randomized at admission on a 1:1 basis to be inducted onto extended-release buprenorphine (XRB) at the time of admission (experimental condition) or remain in SLB (E-TAU; all participants will also receive naloxone). The two approaches will be compared with regard to (1) the percentage of participants released from jail with at least 7 days of buprenorphine in their system, (2) percentage of participants continuing MOUD treatment in the community, and (3) infractions related to buprenorphine diversion.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
Extended-Release Buprenorphine (XRB)
Sublingual Buprenorphine (SLB)
Conditions
Locations
Tufts University Health Sciences
Boston, Massachusetts 02111
United States
Baystate Health
Springfield, Massachusetts 01199
United States
Middlesex County House of Corrections
New Brunswick, New Jersey 08902
United States
NYU Langone Health - 180 Madison Ave
New York, New York 10016
United States